During the past decade, University of Alabama at Birmingham Cancer Center conducted 196 clinical trials. In the 10-year time frame, 196 clinical trials started and 181 clinical trials were completed, i.e. on average, 92.3% percent of trials that started reached the finish line to date. In the past 5 years, 73 clinical trials started and 92 clinical trials were completed. i.e. 126% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Alabama at Birmingham Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 159 trials, followed by "Children's Oncology Group" with 96 trials sponsored, "Radiation Therapy Oncology Group" with 58 trials sponsored, "Gynecologic Oncology Group" with 57 trials sponsored and "Alliance for Clinical Trials in Oncology" with 57 trials sponsored. Other sponsors include 243 different institutions and companies that sponsored additional 95 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Alabama at Birmingham Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 391 trials as a collaborator, "NRG Oncology" with 44 trials as a collaborator, "SWOG Cancer Research Network" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator and "Cancer and Leukemia Group B" with 10 trials as a collaborator. Other collaborators include 131 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "University of Alabama at Birmingham Cancer Center" are "Brain and Central Nervous System Tumors" (34 trials), "Lung Cancer" (33 trials), "Breast Cancer" (32 trials), "Leukemia" (32 trials) and "Lymphoma" (28 trials). Many other conditions were trialed in "University of Alabama at Birmingham Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Alabama at Birmingham Cancer Center" are "Drug" (504 trials), "Other" (222 trials), "Biological" (184 trials), "Radiation" (180 trials) and "Procedure" (178 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (122 trials), "Quality-of-Life Assessment" (67 trials), "radiation therapy" (67 trials), "Questionnaire Administration" (46 trials) and "cisplatin" (41 trials). Other intervention names were less common.

The vast majority of trials in "University of Alabama at Birmingham Cancer Center" are 509 trials for "All" genders, 123 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "University of Alabama at Birmingham Cancer Center". 1 are not yet recruiting, 73 are recruiting, 147 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 350 completed trials in University of Alabama at Birmingham Cancer Center, 9 suspended trials, and 47 terminated clinical trials to date.

Out of the total trials that were conducted in University of Alabama at Birmingham Cancer Center, 120 "Phase 1" clinical trials were conducted, 311 "Phase 2" clinical trials and 236 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 25 trials that are defined as “Not Applicable".